Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management.

Misselwitz B, Butter M, Verbeke K, Fox MR.

Gut. 2019 Aug 19. pii: gutjnl-2019-318404. doi: 10.1136/gutjnl-2019-318404. [Epub ahead of print] Review.

2.

Characteristics, management and outcomes of very preterm triplets in 19 European regions.

Dudenhausen JW, Misselwitz B, Piedvache A, Maier RF, Weber T, Zeitlin J, Schmidt S; EPICE Research Group.

Int J Gynaecol Obstet. 2019 Aug 11. doi: 10.1002/ijgo.12939. [Epub ahead of print]

PMID:
31402446
3.

Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease.

Schreiner P, Yilmaz B, Rossel JB, Franc Y, Misselwitz B, Scharl M, Zeitz J, Frei P, Greuter T, Vavricka SR, Pittet V, Siebenhüner A, Juillerat P, von Känel R, Macpherson AJ, Rogler G, Biedermann L; Swiss IBD Cohort Study Group.

United European Gastroenterol J. 2019 Jul;7(6):767-781. doi: 10.1177/2050640619841249. Epub 2019 Mar 27.

4.

Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.

Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Schönenberger D, Rajski M, Hoogewijs D, Knauf F, Misselwitz B, Frey-Wagner I, Rogler G, Ackermann D, Ponte B, Pruijm M, Leichtle A, Fiedler GM, Bochud M, Ballotta V, Hofmann S, Perwad F, Föller M, Lang F, Wenger RH, Frew I, Wagner CA.

Kidney Int. 2019 May 14. pii: S0085-2538(19)30465-X. doi: 10.1016/j.kint.2019.04.009. [Epub ahead of print]

PMID:
31301888
5.

The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.

Raselli T, Wyss A, Gonzalez Alvarado MN, Weder B, Mamie C, Spalinger MR, Van Haaften WT, Dijkstra G, Sailer AW, Imenez Silva PH, Wagner CA, Tosevski V, Leibl S, Scharl M, Rogler G, Hausmann M, Misselwitz B.

J Crohns Colitis. 2019 Apr 11. pii: jjz039. doi: 10.1093/ecco-jcc/jjz039. [Epub ahead of print]

PMID:
31220227
6.

Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis.

Raselli T, Hearn T, Wyss A, Atrott K, Peter A, Frey-Wagner I, Spalinger MR, Maggio EM, Sailer AW, Schmitt J, Schreiner P, Moncsek A, Mertens J, Scharl M, Griffiths WJ, Bueter M, Geier A, Rogler G, Wang Y, Misselwitz B.

J Lipid Res. 2019 Jul;60(7):1270-1283. doi: 10.1194/jlr.M093229. Epub 2019 May 21.

7.

False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.

Valota M, Thienemann F, Misselwitz B.

BMJ Case Rep. 2019 May 10;12(5). pii: e228356. doi: 10.1136/bcr-2018-228356.

PMID:
31079040
8.

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.

Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J; Swiss IBD Cohort Study Group.

PLoS One. 2019 Apr 25;14(4):e0215738. doi: 10.1371/journal.pone.0215738. eCollection 2019.

9.

Early Initiation of Anti-Tnf is Associated with Favourable Long-Term Outcome in Crohn's Disease: 10-Year-Follow-Up Data from the Swiss IBD Cohort Study.

Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2019 Mar 7. pii: jjz057. doi: 10.1093/ecco-jcc/jjz057. [Epub ahead of print]

PMID:
30854548
10.

The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.

Wyss A, Raselli T, Perkins N, Ruiz F, Schmelczer G, Klinke G, Moncsek A, Roth R, Spalinger MR, Hering L, Atrott K, Lang S, Frey-Wagner I, Mertens JC, Scharl M, Sailer AW, Pabst O, Hersberger M, Pot C, Rogler G, Misselwitz B.

Mucosal Immunol. 2019 May;12(3):733-745. doi: 10.1038/s41385-019-0140-x. Epub 2019 Feb 11.

11.

[Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota].

Marchukov D, Misselwitz B.

Ther Umsch. 2019 Jan;75(5):273-279. doi: 10.1024/0040-5930/a000999. Review. German.

PMID:
30700240
12.

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G; Swiss IBD Cohort Study Group, Anderegg C, Bauerfeind P, Beglinger C, Begré S, Belli D, Bengoa J, Biedermann L, Bigler B, Binek J, Blattmann M, Boehm S, Borovicka J, Braegger P, Brunner N, Bühr P, Burnand B, Burri E, Buyse S, Cremer M, Criblez DH, de Saussure P, Degen L, Delarive J, Doerig C, Dora B, Dorta G, Egger M, Ehmann T, El-Wafa A, Engelmann M, Ezri J, Felley C, Fliegner M, Fournier N, Fraga M, Frei P, Fried M, Froehlich F, Funk C, Furlano RI, Gallot-Lavallée S, Geyer M, Girardin M, Golay D, Grandinetti T, Gysi B, Haack H, Haarer J, Helbling B, Hengstler P, Herzog D, Hess C, Heyland K, Hinterleitner T, Hiroz P, Hirschi C, Hruz P, Iwata R, Jost R, Juillerat P, Keller C, Knellwolf C, Knoblauch C, Köhler H, Koller R, Krieger-Grübel C, Kullak-Ublick G, Künzler P, Landolt M, Lange R, Lehmann FS, Macpherson A, Maerten P, Maillard H, Manser C, Manz M, Marbet U, Marx G, Matter C, Meier R, Mendanova M, Michetti P, Misselwitz B, Morell B, Mosler P, Mottet C, Müller C, Müller P, Müllhaupt B, Münger-Beyeler C, Musso L, Nagy A, Neagu M, Nichita C, Niess J, Nydegger A, Obialo N, Oneta C, Oropesa C, Peter U, Peternac D, Petit LM, Piccoli-Gfeller F, Pilz JB, Pittet V, Raschle N, Rentsch R, Restellini RS, Richterich JP, Rihs S, Ritz MA, Roduit J, Rogler D, Rogler G, Rossel JB, Rueger V, Saner G, Sauter B, Sawatzki M, Schäppi M, Scharl M, Scharl S, Schelling M, Schibli S, Schlauri H, Uebelhart SS, Schnegg JF, Schoepfer A, Seibold F, Seirafi M, Semadeni GM, Semela D, Senning A, Sidler M, Sokollik C, Spalinger J, Spangenberger H, Stadler P, Steuerwald M, Straumann A, Straumann-Funk B, Sulz M, Suter A, Thorens J, Tiedemann S, Tutuian R, Vavricka S, Viani F, Vögtlin J, Von Känel R, Vonlaufen A, Vouillamoz D, Vulliamy R, Wermuth J, Werner H, Wiesel P, Wiest R, Wylie T, Zeitz J, Zimmermann D.

Int J Epidemiol. 2019 Jan 27. doi: 10.1093/ije/dyy298. [Epub ahead of print] No abstract available.

PMID:
30689927
13.

Mode of delivery and mortality and morbidity for very preterm singleton infants in a breech position: A European cohort study.

Schmidt S, Norman M, Misselwitz B, Piedvache A, Huusom LD, Varendi H, Barros H, Cammu H, Blondel B, Dudenhausen J, Zeitlin J, Weber T; EPICE Research Group.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:96-102. doi: 10.1016/j.ejogrb.2019.01.003. Epub 2019 Jan 11.

PMID:
30682601
14.

Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review.

Ran T, Cheng CY, Misselwitz B, Brenner H, Ubels J, Schlander M.

Clin Gastroenterol Hepatol. 2019 Jan 16. pii: S1542-3565(19)30034-5. doi: 10.1016/j.cgh.2019.01.014. [Epub ahead of print]

PMID:
30659991
15.

The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.

Tcymbarevich IV, Eloranta JJ, Rossel JB, Obialo N, Spalinger M, Cosin-Roger J, Lang S, Kullak-Ublick GA, Wagner CA, Scharl M, Seuwen K, Ruiz PA, Rogler G, de Vallière C, Misselwitz B; Swiss IBD Cohort Study Group.

BMC Gastroenterol. 2019 Jan 7;19(1):2. doi: 10.1186/s12876-018-0922-8.

16.

Young GI angle: Planning the statistical analysis of the results.

Kirchgesner J, Misselwitz B.

United European Gastroenterol J. 2018 Dec;6(10):1598-1600. doi: 10.1177/0391560318813777. Epub 2018 Nov 29. No abstract available.

17.

The growing discrepancy between resident training in colonic surgery and the rising number of general surgery graduates.

Käser SA, Rickenbacher A, Cabalzar-Wondberg D, Schneider M, Dietrich D, Misselwitz B, Clavien PA, Turina M.

Int J Colorectal Dis. 2019 Mar;34(3):423-429. doi: 10.1007/s00384-018-3209-1. Epub 2018 Dec 6.

PMID:
30523397
18.

[Is it Reasonable to Establish an Independently Managed Obstetric Unit in a Small Hospital and Does it Result in Measurable Changes in Quality of Maternity Care?]

Reitter A, Doehring N, Maden Z, Hessler PA, Misselwitz B.

Z Geburtshilfe Neonatol. 2019 Jun;223(3):147-156. doi: 10.1055/a-0749-9024. Epub 2018 Dec 7. German.

PMID:
30536274
19.

Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel Disease.

Tcymbarevich I, Richards SM, Russo G, Kühn-Georgijevic J, Cosin-Roger J, Baebler K, Lang S, Bengs S, Atrott K, Bettoni C, Gruber S, Frey-Wagner I, Scharl M, Misselwitz B, Wagner CA, Seuwen K, Rogler G, Ruiz PA, Spalinger M, de Vallière C.

J Crohns Colitis. 2019 Feb 1;13(2):245-258. doi: 10.1093/ecco-jcc/jjy152.

PMID:
30535144
20.

Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study.

Wotzka SY, Kreuzer M, Maier L, Zünd M, Schlumberger M, Nguyen B, Fox M, Pohl D, Heinrich H, Rogler G, Biedermann L, Scharl M, Sunagawa S, Hardt WD, Misselwitz B.

PLoS One. 2018 Oct 25;13(10):e0206214. doi: 10.1371/journal.pone.0206214. eCollection 2018.

21.

Duration and Time Trends in Hospital Stay for Very Preterm Infants Differ Across European Regions.

Maier RF, Blondel B, Piedvache A, Misselwitz B, Petrou S, Van Reempts P, Franco F, Barros H, Gadzinowski J, Boerch K, van Heijst A, Draper ES, Zeitlin J; MOSAIC and EPICE Research Groups.

Pediatr Crit Care Med. 2018 Dec;19(12):1153-1161. doi: 10.1097/PCC.0000000000001756.

22.

Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.

Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T.

Am J Gastroenterol. 2019 Jan;114(1):116-126. doi: 10.1038/s41395-018-0360-9.

PMID:
30333538
23.

Abnormal esophageal motility during a solid test meal in systemic sclerosis-detection even in very early disease and association with disease progression.

Bütikofer S, Jordan S, Sauter M, Hollenstein M, Heinrich H, Freitas-Queiroz N, Kuntzen T, Ang D, Oberacher M, Maurer B, Schwizer W, Fox M, Distler O, Misselwitz B.

Neurogastroenterol Motil. 2019 Jan;31(1):e13480. doi: 10.1111/nmo.13480. Epub 2018 Oct 1.

PMID:
30276930
24.

Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Gassmann D, Weiler S, Mertens JC, Reiner CS, Vrugt B, Nägeli M, Mangana J, Müllhaupt B, Jenni F, Misselwitz B.

Transplant Direct. 2018 Jul 20;4(8):e376. doi: 10.1097/TXD.0000000000000814. eCollection 2018 Aug.

25.

The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding.

Vavricka SR, Heinrich H, Buetikofer S, Breitenmoser F, Burri E, Schneider-Yin X, Barman-Aksoezen J, Biedermann L, Scharl M, Zeitz J, Rogler G, Misselwitz B, Sauter M.

United European Gastroenterol J. 2018 Aug;6(7):1007-1014. doi: 10.1177/2050640618774416. Epub 2018 May 28.

26.

The Fructose Hydrogen Breath Test: Nothing Behind the Sweet Fog?

Misselwitz B, Fox M.

Digestion. 2019;99(3):191-193. doi: 10.1159/000491747. Epub 2018 Sep 13. No abstract available.

27.

Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis.

Hutter S, van Haaften WT, Hünerwadel A, Baebler K, Herfarth N, Raselli T, Mamie C, Misselwitz B, Rogler G, Weder B, Dijkstra G, Meier CF, de Vallière C, Weber A, Imenez Silva PH, Wagner CA, Frey-Wagner I, Ruiz PA, Hausmann M.

J Crohns Colitis. 2018 Nov 15;12(11):1348-1358. doi: 10.1093/ecco-jcc/jjy118.

28.

High-Resolution Anorectal Manometry - New Insights in the Diagnostic Assessment of Functional Anorectal Disorders.

Heinrich H, Misselwitz B.

Visc Med. 2018 Apr;34(2):134-139. doi: 10.1159/000488611. Epub 2018 Apr 20. Review.

29.

Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.

Kadelka C, Liechti T, Ebner H, Schanz M, Rusert P, Friedrich N, Stiegeler E, Braun DL, Huber M, Scherrer AU, Weber J, Uhr T, Kuster H, Misselwitz B, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Kouyos RD, Günthard HF, Trkola A; Swiss HIV Cohort Study.

J Exp Med. 2018 Jun 4;215(6):1589-1608. doi: 10.1084/jem.20180246. Epub 2018 May 24.

30.

Epidemiology and Outcome of Major Congenital Malformations in a Large German County.

Wittekindt B, Schloesser R, Doberschuetz N, Salzmann-Manrique E, Grossmann J, Misselwitz B, Rolle U.

Eur J Pediatr Surg. 2019 Jun;29(3):282-289. doi: 10.1055/s-0038-1642630. Epub 2018 May 1.

PMID:
29715697
31.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group .

J Crohns Colitis. 2018 Jun 28;12(7):811-818. doi: 10.1093/ecco-jcc/jjy040.

PMID:
29617750
32.

Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people.

Butter M, Weiler S, Biedermann L, Scharl M, Rogler G, Bischoff-Ferrari HA, Misselwitz B.

Maturitas. 2018 Apr;110:71-78. doi: 10.1016/j.maturitas.2018.01.015. Epub 2018 Jan 31. Review.

PMID:
29563038
33.

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.

Greuter T, Franc Y, Kaelin M, Schoepfer AM, Schreiner P, Zeitz J, Scharl M, Misselwitz B, Straumann A, Vavricka SR, Rogler G, von Känel R, Biedermann L.

Therap Adv Gastroenterol. 2018 Feb 19;11:1756283X18757715. doi: 10.1177/1756283X18757715. eCollection 2018.

34.

Multilocular Hepatic Abscess Formation and Sepsis due to Yersinia enterocolitica in a Patient with Hereditary Hemochromatosis and Type 2 Diabetes Mellitus.

Sauter M, Vavricka SR, Locher P, Preiswerk B, Weishaupt D, Meier CA, Misselwitz B.

Case Rep Gastroenterol. 2017 Nov 29;11(3):724-728. doi: 10.1159/000481932. eCollection 2017 Sep-Dec.

35.

Cohort study from 11 European countries highlighted differences in the use and efficacy of hypothermia prevention strategies after very preterm birth.

Wilson E, Zeitlin J, Piedvache A, Misselwitz B, Christensson K, Maier RF, Norman M, Edstedt Bonamy AK; EPICE Research Group.

Acta Paediatr. 2018 Jun;107(6):958-966. doi: 10.1111/apa.14230. Epub 2018 Feb 19.

PMID:
29356061
36.

Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD-Authors' reply.

Lang BM, Beerenwinkel N, Misselwitz B.

Aliment Pharmacol Ther. 2018 Jan;47(2):307-308. doi: 10.1111/apt.14447. No abstract available.

37.

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.

Lutz C, Weder B, Hünerwadel A, Fagagnini S, Lang B, Beerenwinkel N, Rossel JB, Rogler G, Misselwitz B, Hausmann M.

Sci Rep. 2017 Dec 15;7(1):17678. doi: 10.1038/s41598-017-17755-7.

38.

Implementation of stroke teams and simulation training shortened process times in a regional stroke network-A network-wide prospective trial.

Tahtali D, Bohmann F, Kurka N, Rostek P, Todorova-Rudolph A, Buchkremer M, Abruscato M, Hartmetz AK, Kuhlmann A, Henke C, Stegemann A, Menon S, Misselwitz B, Reihs A, Weidauer S, Thonke S, Meyding-Lamadé U, Singer O, Steinmetz H, Pfeilschifter W.

PLoS One. 2017 Dec 5;12(12):e0188231. doi: 10.1371/journal.pone.0188231. eCollection 2017.

39.

Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease.

Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2018 Jan;47(1):55-66. doi: 10.1111/apt.14378. Epub 2017 Oct 20.

40.

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.

Fagagnini S, Heinrich H, Rossel JB, Biedermann L, Frei P, Zeitz J, Spalinger M, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M, Misselwitz B.

PLoS One. 2017 Oct 12;12(10):e0185193. doi: 10.1371/journal.pone.0185193. eCollection 2017.

41.

One decade of oral anticoagulation in stroke patients: Results from a large country-wide hospital-based registry.

Tanislav C, Allendörfer J, Pfeilschifter W, Fuest S, Stein M, Meyer M, Reuter I, Kaps M, Misselwitz B.

Int J Stroke. 2018 Apr;13(3):308-312. doi: 10.1177/1747493017733928. Epub 2017 Sep 27.

PMID:
28952913
42.

Pacemaker implantation and mortality: no role as a quality control indicator: Author's reply.

Nowak B, Misselwitz B, Przibille O, Mehta RH.

Europace. 2017 Sep 1;19(9):1587. doi: 10.1093/europace/eux270. No abstract available.

PMID:
28934411
43.

Decision-to-Delivery Time and Perinatal Complications in Emergency Cesarean Section.

Heller G, Bauer E, Schill S, Thomas T, Louwen F, Wolff F, Misselwitz B, Schmidt S, Veit C.

Dtsch Arztebl Int. 2017 Sep 4;114(35-36):589-596. doi: 10.3238/arztebl.2017.0589.

44.

What is normal and abnormal in lactose digestion?

Misselwitz B, Fox M.

Lancet Gastroenterol Hepatol. 2017 Oct;2(10):696-697. doi: 10.1016/S2468-1253(17)30180-2. Epub 2017 Jul 7. No abstract available.

PMID:
28690132
45.

Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study.

Ang D, Misselwitz B, Hollenstein M, Knowles K, Wright J, Tucker E, Sweis R, Fox M.

Lancet Gastroenterol Hepatol. 2017 Sep;2(9):654-661. doi: 10.1016/S2468-1253(17)30148-6. Epub 2017 Jul 3.

PMID:
28684262
46.

Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders.

Hollenstein M, Thwaites P, Bütikofer S, Heinrich H, Sauter M, Ulmer I, Pohl D, Ang D, Eberli D, Schwizer W, Fried M, Distler O, Fox M, Misselwitz B.

Lancet Gastroenterol Hepatol. 2017 Sep;2(9):644-653. doi: 10.1016/S2468-1253(17)30151-6. Epub 2017 Jul 3.

PMID:
28684261
47.

Surveillance of anal carcinoma after radiochemotherapy : A retrospective analysis of 80 patients.

Sauter M, Vavricka SR, Keilholz G, Heinrich H, Winder T, Kranzbühler H, Lombriser N, Misselwitz B.

Strahlenther Onkol. 2017 Aug;193(8):639-647. doi: 10.1007/s00066-017-1159-0. Epub 2017 Jun 26.

PMID:
28653119
48.

Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey.

Vavricka SR, Spasojevic M, Rogler G, Schoepfer AM, Seibold F, Borovicka J, Frei P, Zeitz J, Greuter T, Manser C, Scharl M, Misselwitz B, Straumann A, Michetti P, Biedermann L; Swiss IBDnet.

Dig Dis. 2017;35(5):423-432. doi: 10.1159/000475494. Epub 2017 Jun 9.

49.

CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies.

Prakash MK, Lang B, Heinrich H, Valli PV, Bauerfeind P, Sonnenberg A, Beerenwinkel N, Misselwitz B.

BMC Med Inform Decis Mak. 2017 Jun 5;17(1):80. doi: 10.1186/s12911-017-0458-9.

50.

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study.

Schüle S, Rossel JB, Frey D, Biedermann L, Scharl M, Zeitz J, Freitas-Queiroz N, Kuntzen T, Greuter T, Vavricka SR, Rogler G, Misselwitz B; Swiss IBD cohort study.

Medicine (Baltimore). 2017 Jun;96(22):e6788. doi: 10.1097/MD.0000000000006788.

Supplemental Content

Loading ...
Support Center